Cargando…
Evolving BioAssay Ontology (BAO): modularization, integration and applications
The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary drug screening data to their maximum potential. We have created the BioAssay Ontology (BAO)...
Autores principales: | Abeyruwan, Saminda, Vempati, Uma D, Küçük-McGinty, Hande, Visser, Ubbo, Koleti, Amar, Mir, Ahsan, Sakurai, Kunie, Chung, Caty, Bittker, Joshua A, Clemons, Paul A, Brudz, Steve, Siripala, Anosha, Morales, Arturo J, Romacker, Martin, Twomey, David, Bureeva, Svetlana, Lemmon, Vance, Schürer, Stephan C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108877/ https://www.ncbi.nlm.nih.gov/pubmed/25093074 http://dx.doi.org/10.1186/2041-1480-5-S1-S5 |
Ejemplares similares
-
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
por: Visser, Ubbo, et al.
Publicado: (2011) -
Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO)
por: Vempati, Uma D., et al.
Publicado: (2012) -
Facilitating transparency in spinal cord injury studies using data standards and ontologies
por: Lemmon, Vance P., et al.
Publicado: (2014) -
RegenBase: a knowledge base of spinal cord injury biology for translational research
por: Callahan, Alison, et al.
Publicado: (2016) -
Drug target ontology to classify and integrate drug discovery data
por: Lin, Yu, et al.
Publicado: (2017)